Exact Mass: 502.16997060000006
Exact Mass Matches: 502.16997060000006
Found 59 metabolites which its exact mass value is equals to given mass value 502.16997060000006,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Clozapine glucuronide
C24H27ClN4O6 (502.16190320000004)
Clozapine glucuronide is a metabolite of clozapine. Clozapine (sold as Clozaril, Gen-Clozapine in Canada, Azaleptin, Leponex, Fazaclo, Froidir; Denzapine, Zaponex in the UK; Klozapol in Poland, Clopine in Australia and New Zealand) is an atypical antipsychotic medication used in the treatment of schizophrenia, and is also used off-label in the treatment of bipolar disorder. Wyatt. R and Chew. (Wikipedia)
Adozelesin
Inolitazone
C27H26N4O4S (502.16746760000007)
C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D000970 - Antineoplastic Agents
2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide
D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D004791 - Enzyme Inhibitors
Demethoxyisogemichalcone C
6-O-apio-beta-furanosyl-[5-O-(trans-dimethoxycinnamic acid)]-alpha/beta-glucopyranoside
10-O-(4-O-methylsuccinoyl)geniposide|[(1S,4aS,7aS)-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydro-4-(methoxycarbonyl)-cyclopenta[c]pyran-7-yl]methyl methyl butanedioate
3-[(4-O-caffeoyl-beta-D-glucopyranosyloxy)methyl]-2,5-dimethoxy-3-hydroxytetrahydrofuran|cibotiumbaroside B
3-[??-Hydroxymethyl-(E)-??-methylallyl]-2,4,2,4-tetrahydroxychalcone 11-O-coumarate|isogemichalcone B
(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl 6-O(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside|clemomandshuricoside B
9-Nitro Minocycline Sulfate Salt (85\\%)
C23H26N4O9 (502.16997060000006)
Phenyl 3,6-diazido-3,6-dideoxy-2,4-bis-O-(phenylmethyl)-1-thio-beta-D-glucopyranoside
C26H26N6O3S (502.17870060000007)
(2R)-2-amino-4-[4-[(1R)-2-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]amino]-1-(hydroxyamino)-2-oxoethyl]phenoxy]butanoic acid
C23H26N4O9 (502.16997060000006)
3-(4-methylphenyl)-N-[3-(4-morpholinylsulfonyl)phenyl]-1-phenyl-4-pyrazolecarboxamide
C27H26N4O4S (502.16746760000007)
2-Hydroxy-5-[(4-methoxyphenyl)sulfamoyl]benzoic acid [2-[1-(3-bicyclo[2.2.1]heptanyl)ethylamino]-2-oxoethyl] ester
3-(4-{7-[(5-carboxypentyl)(ethyl)amino]-2-oxo-2H-chromen-3-yl}pyridinium-1-yl)propane-1-sulfonate
[(4R)-4-[2-(benzenesulfonyl)ethyl]-2-[4-(3-hydroxypropoxy)phenyl]-5H-oxazol-4-yl]-(4-morpholinyl)methanone
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)sulfonylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
Arg-AMS
C16H26N10O7S (502.17065660000003)
Arg-AMS (compound 24) is a potent nanomolar inhibitor of arginyl tRNA synthetase, which displays tightly bound inhibitory characteristics for the A-domains in non-ribosomal peptide synthetases (NRPS) enzymes[1].
3,22-dimethoxy-13-methyl-12-methylidene-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(22),2(10),3,8,15,17(21)-hexaen-11-yl benzoate
(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-{[(2r,3s,5s)-3-hydroxy-2,5-dimethoxyoxolan-3-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(3s)-3-hydroxy-5-{[(2e)-3-(3-hydroxy-5-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-en-1-yl]oxy}-3-methyl-5-oxopentanoic acid
(2r,3r,4r,5r,6r)-4,5-dihydroxy-6-{[(2r,3s,5s)-3-hydroxy-2,5-dimethoxyoxolan-3-yl]methoxy}-2-(hydroxymethyl)oxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
3'-[γ-hydroxymethyl-(e)-γ-methylallyl]-2,4,2',4'-tetrahydroxychalcone 11'-o-coumarate
{"Ingredient_id": "HBIN009772","Ingredient_name": "3'-[\u03b3-hydroxymethyl-(e)-\u03b3-methylallyl]-2,4,2',4'-tetrahydroxychalcone 11'-o-coumarate","Alias": "NA","Ingredient_formula": "C29H26O8","Ingredient_Smile": "CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=C(C=C(C=C2)O)O)O)COC(=O)C=CC3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10505","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
methyl 6-[(1s)-1-[4-(methoxycarbonyl)phenazin-1-yl]ethyl]phenazine-1-carboxylate
(1r,2s,3r)-2-(2,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-1-[(r)-(4-hydroxyphenyl)(methoxy)methyl]-2,3-dihydro-1h-indene-4,6-diol
(11r,12s,15s)-11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one
C27H35BrO4 (502.17185700000005)
(8r,11r,12s,15s)-11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one
C27H35BrO4 (502.17185700000005)
4,5-dihydroxy-6-[(3-hydroxy-2,5-dimethoxyoxolan-3-yl)methoxy]-2-(hydroxymethyl)oxan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(3r,7s,8s,11s,13s,16s)-7-bromo-22-hydroxy-8,13-dimethyl-4-methylidene-16-(prop-1-en-2-yl)-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one
C27H35BrO4 (502.17185700000005)
4-{3-[(2e)-3-(2,4-dihydroxyphenyl)prop-2-enoyl]-2,6-dihydroxyphenyl}-2-methylbut-2-en-1-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(11r,13s)-3,22-dimethoxy-13-methyl-12-methylidene-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(22),2(10),3,8,15,17(21)-hexaen-11-yl benzoate
(7s,8s,11s,13s,16s)-7-bromo-22-hydroxy-8,13-dimethyl-4-methylidene-16-(prop-1-en-2-yl)-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one
C27H35BrO4 (502.17185700000005)
3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
methyl 6-{1-[4-(methoxycarbonyl)phenazin-1-yl]ethyl}phenazine-1-carboxylate
11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one
C27H35BrO4 (502.17185700000005)
7-bromo-22-hydroxy-8,13-dimethyl-4-methylidene-16-(prop-1-en-2-yl)-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one
C27H35BrO4 (502.17185700000005)
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
(8s,11r,12s,15s)-11-bromo-12,21-dihydroxy-4,7,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,6,18,20-pentaen-17-one
C27H35BrO4 (502.17185700000005)